{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:11Z","timestamp":1790710931434,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774291"],"award-info":[{"award-number":["81774291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes is an important risk factor for liver cancer, but its mechanism is unknown. Corosolic acid (CA) has been proven to have both hypoglycemic and antitumor effects, so revealing the function of CA can help us understand the relationship between diabetes and liver cancer. In previous studies, we confirmed that CA can effectively inhibit the expression of YAP, an important oncoprotein in HCC cells, and the proliferation of HCC cells. In addition, we also found that <jats:italic>O<\/jats:italic>-GlcNAcylation plays an indispensable role in HCC tumorigenesis. However, it is not clear whether CA can inhibit the effect of <jats:italic>O<\/jats:italic>-GlcNAcylation on HCC cells. In this study, the antitumor ability of CA was investigated by inhibiting the <jats:italic>O<\/jats:italic>-GlcNAcylation level and its corresponding mechanism. The results showed that HG (high glucose) could promote the proliferation of liver cancer cells, while CA could inhibit cell growth under HG conditions and tumor growth in a xenotransplantation model. CA can inhibit the activation of the HBP pathway and reduce the expression of YAP and OGT under HG conditions. Importantly, we found that CA can reduce YAP expression and <jats:italic>O<\/jats:italic>-GlcNAcylation by inhibiting the activity of CDK19. Overexpression of CDK19 partially reversed the CA-induced decrease in YAP and <jats:italic>O<\/jats:italic>-GlcNAcylation. This is the first evidence that CA can reduce the proliferative capacity of cells with high glucose levels and further inhibit tumor growth by inactivating the CDK19\/YAP\/<jats:italic>O<\/jats:italic>-GlcNAcylation pathway, suggesting that CA is a candidate drug for the development of treatments against diabetes-associated liver cancer.<\/jats:p>","DOI":"10.1038\/s41419-021-04164-y","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T14:47:59Z","timestamp":1632926879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Congcong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-2864","authenticated-orcid":false,"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-6525","authenticated-orcid":false,"given":"Yongchun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"4164_CR1","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","volume":"13","author":"AG Singal","year":"2015","unstructured":"Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015;13:2140\u201351.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"4164_CR2","doi-asserted-by":"crossref","unstructured":"El-Serag H, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369\u201380.","DOI":"10.1016\/j.cgh.2005.12.007"},{"key":"4164_CR3","unstructured":"Zhang Q, Li Y, Liang T, Lu X, Liu X, Zhang C, et al. Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation. Am J Cancer Res. 2015;5:1762\u201374."},{"key":"4164_CR4","doi-asserted-by":"crossref","unstructured":"Bertot LC, Adams LA. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2019;13:179-87.","DOI":"10.1080\/17474124.2019.1549989"},{"key":"4164_CR5","doi-asserted-by":"publisher","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","volume":"17","author":"H Jarvis","year":"2020","unstructured":"Jarvis H, Craig D, Barker R, Spiers G, Stow D, Anstee Q, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies. PLoS Med. 2020;17:e1003100.","journal-title":"PLoS Med."},{"key":"4164_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2009.09.022","volume":"318","author":"C Teo","year":"2010","unstructured":"Teo C, Wollaston-Hayden E, Wells L. Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol Cell Endocrinol. 2010;318:44\u201353.","journal-title":"Mol Cell Endocrinol"},{"key":"4164_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2014.04.014","volume":"356","author":"J Singh","year":"2015","unstructured":"Singh J, Zhang K, Wu J, Yang XJCl. O-GlcNAc signaling in cancer metabolism and epigenetics. Cancer Lett. 2015;356:244\u201350.","journal-title":"Cancer Lett"},{"key":"4164_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10238-014-0318-1","volume":"15","author":"K Starska","year":"2015","unstructured":"Starska K, Forma E, Brzezi\u0144ska-B\u0142aszczyk E, Lewy-Trenda I, Bry\u015b M, J\u00f3\u017awiak P, et al. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer. Clin Exp Med. 2015;15:455\u201368.","journal-title":"Clin Exp Med"},{"key":"4164_CR9","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1158\/0008-5472.CAN-13-0549","volume":"73","author":"H Itkonen","year":"2013","unstructured":"Itkonen H, Minner S, Guldvik I, Sandmann M, Tsourlakis M, Berge V, et al. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 2013;73:5277\u201387.","journal-title":"Cancer Res"},{"key":"4164_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrc3114","volume":"11","author":"C Slawson","year":"2011","unstructured":"Slawson C, GJNrC Hart. O-GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer. 2011;11:678\u201384.","journal-title":"Nat Rev Cancer"},{"key":"4164_CR11","doi-asserted-by":"crossref","unstructured":"Yao B, Xu Y, Wang J, Qiao Y, Zhang Y, Zhang X, et al. Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells. Cell Signal. 2016;28:1703\u201312.","DOI":"10.1016\/j.cellsig.2016.08.003"},{"key":"4164_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2337\/db15-1057","volume":"65","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, Zhang X, Zhang Y, Wang Y, Xu Y, Liu X, et al. High glucose stimulates tumorigenesis in hepatocellular carcinoma cells through AGER-dependent O-GlcNAcylation of c-Jun. Diabetes. 2016;65:619\u201332.","journal-title":"Diabetes"},{"key":"4164_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15280","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Qiao Y, Wu Q, Chen Y, Zou S, Liu X, et al. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis. Nat Commun. 2017;8:15280.","journal-title":"Nat Commun."},{"key":"4164_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.devcel.2016.03.002","volume":"37","author":"M Oudhoff","year":"2016","unstructured":"Oudhoff M, Braam M, Freeman S, Wong D, Rattray D, Wang J, et al. SETD7 controls intestinal regeneration and tumorigenesis by regulating Wnt\/\u03b2-Catenin and Hippo\/YAP signaling. Dev Cell. 2016;37:47\u201357.","journal-title":"Dev Cell"},{"key":"4164_CR15","doi-asserted-by":"crossref","unstructured":"Zhao B, Wei X, Li W, Udan R, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361.","DOI":"10.1101\/gad.1602907"},{"key":"4164_CR16","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1038\/onc.2012.520","volume":"32","author":"MJO Sudol","year":"2013","unstructured":"Sudol MJO. YAP1 oncogene and its eight isoforms. Oncogene. 2013;32:3922.","journal-title":"Oncogene"},{"key":"4164_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1158\/1078-0432.CCR-14-1374","volume":"21","author":"K Lee","year":"2015","unstructured":"Lee K, Lee S, Kim S, Sohn B, Lee H, Jang H, et al. Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients. Clin Cancer Res. 2015;21:357\u201364.","journal-title":"Clin Cancer Res"},{"key":"4164_CR18","doi-asserted-by":"crossref","unstructured":"Tu B, Yao J, Ferri-Borgogno S, Zhao J, Chen S, Wang Q, et al. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. JCI insight. 2019;4:e130811.","DOI":"10.1172\/jci.insight.130811"},{"key":"4164_CR19","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/biot.200900207","volume":"4","author":"G Sivakumar","year":"2009","unstructured":"Sivakumar G, Vail D, Nair V, Medina-Bolivar F, Lay JJBJ. Plant-based corosolic acid: future anti-diabetic drug? Biotechnol J. 2009;4:1704\u201311.","journal-title":"Biotechnol J"},{"key":"4164_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2008.01.020","volume":"584","author":"L Shi","year":"2008","unstructured":"Shi L, Zhang W, Zhou Y, Zhang Y, Li J, Hu L, et al. Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol. 2008;584:21\u20139.","journal-title":"Eur J Pharmacol"},{"key":"4164_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cellsig.2016.11.001","volume":"29","author":"Y Xu","year":"2017","unstructured":"Xu Y, Zhao Y, Xu Y, Guan Y, Zhang X, Chen Y, et al. Blocking inhibition to YAP by ActinomycinD enhances anti-tumor efficacy of Corosolic acid in treating liver cancer. Cell Signal. 2017;29:209\u201317.","journal-title":"Cell Signal"},{"key":"4164_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/21655979.2020.1855914","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G, Bai X, Jiang G, Jin S, Wang Q, Wang A, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021;12:30\u201343.","journal-title":"Bioengineered."},{"key":"4164_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/21655979.2021.1889109","volume":"12","author":"Y Fang","year":"2021","unstructured":"Fang Y, Yan C, Zhao Q, Xu J, Liu Z, Gao J, et al. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered. 2021;12:720\u201335.","journal-title":"Bioengineered."},{"key":"4164_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/14756366.2021.1890726","volume":"36","author":"A Alsfouk","year":"2021","unstructured":"Alsfouk A. Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy. J Enzym Inhib Med Chem. 2021;36:693\u2013706.","journal-title":"J Enzym Inhib Med Chem"},{"key":"4164_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbrc.2012.04.124","volume":"422","author":"WB Dias","year":"2012","unstructured":"Dias WB, Cheung WD, Hart GW. O-GlcNAcylation of kinases. Biochem Biophys Res Commun. 2012;422:224\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"4164_CR26","first-page":"576.e6","volume":"50","author":"X Li","year":"2019","unstructured":"Li X, Gong W, Wang H, Li T, Attri KS, Lewis RE, et al. O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine\/threonine-protein kinase 3. Immunity. 2019;50:576.e6\u201390.e6.","journal-title":"Immunity."},{"key":"4164_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/ijms22010141","volume":"22","author":"G Anderson","year":"2020","unstructured":"Anderson G. Tumour microenvironment: roles of the Aryl hydrocarbon receptor, O-GlcNAcylation, acetyl-CoA and melatonergic pathway in regulating dynamic metabolic interactions across cell types-tumour microenvironment and metabolism. Int J Mol Sci. 2020;22:141.","journal-title":"Int J Mol Sci"},{"key":"4164_CR28","doi-asserted-by":"crossref","unstructured":"Xu Y, Sheng X, Zhao T, Zhang L, Ruan Y, Lu H. O-GlcNAcylation of MEK2 promotes the proliferation and migration of breast cancer cells. Glycobiology. 2020;31:571\u201381.","DOI":"10.1093\/glycob\/cwaa103"},{"key":"4164_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CEJ.0000000000000038","volume":"24","author":"J Chen","year":"2015","unstructured":"Chen J, Han Y, Xu C, Xiao T, Wang B. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies. Eur J Cancer Prev. 2015;24:89\u201399.","journal-title":"Eur J Cancer Prev"},{"key":"4164_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/nature05815","volume":"446","author":"GW Hart","year":"2007","unstructured":"Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017\u201322.","journal-title":"Nature."},{"key":"4164_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017;18:452\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4164_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11123","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma B, Cheng H, Gao R, Mu C, Chen L, Wu S, et al. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-\u03b2 signalling pathways. Nat Commun. 2016;7:11123.","journal-title":"Nat Commun"},{"key":"4164_CR33","doi-asserted-by":"crossref","unstructured":"Samji P, Rajendran M, Warrier V, Ganesh A, Devarajan K. Regulation of Hippo signaling pathway in cancer: a microRNA perspective. Cell Signal. 2020;78:109858.","DOI":"10.1016\/j.cellsig.2020.109858"},{"key":"4164_CR34","doi-asserted-by":"crossref","unstructured":"Emami SS, Zhang D, Yang X. Interaction of the Hippo pathway and phosphatases in tumorigenesis. Cancers. 2020;12:2438.","DOI":"10.3390\/cancers12092438"},{"key":"4164_CR35","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-16-0094","volume":"23","author":"J Bragelmann","year":"2017","unstructured":"Bragelmann J, Klumper N, Offermann A, von Massenhausen A, Bohm D, Deng M, et al. Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer. Clin Cancer Res. 2017;23:1829\u201340.","journal-title":"Clin Cancer Res."},{"key":"4164_CR36","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cells8080821","volume":"8","author":"IB Roninson","year":"2019","unstructured":"Roninson IB, Gyorffy B, Mack ZT, Shtil AA, Shtutman MS, Chen M, et al. Identifying cancers impacted by CDK8\/19. Cells. 2019;8:821.","journal-title":"Cells."},{"key":"4164_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ptr.3664","volume":"26","author":"SJ Stohs","year":"2012","unstructured":"Stohs SJ, Miller H, Kaats GR. A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phytother Res. 2012;26:317\u201324.","journal-title":"Phytother Res"},{"key":"4164_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.phymed.2018.09.011","volume":"50","author":"H Sharma","year":"2018","unstructured":"Sharma H, Kumar P, Deshmukh RR, Bishayee A, Kumar S. Pentacyclic triterpenes: new tools to fight metabolic syndrome. Phytomedicine. 2018;50:166\u201377.","journal-title":"Phytomedicine"},{"key":"4164_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.fct.2017.05.021","volume":"105","author":"QL Cheng","year":"2017","unstructured":"Cheng QL, Li HL, Li YC, Liu ZW, Guo XH, Cheng YJ. CRA(Crosolic Acid) isolated from Actinidia valvata Dunn.Radix induces apoptosis of human gastric cancer cell line BGC823 in vitro via down-regulation of the NF-\u03baB pathway. Food Chem Toxicol. 2017;105:475\u201385.","journal-title":"Food Chem Toxicol"},{"key":"4164_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.fct.2014.02.019","volume":"67","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim YH, Song GY, Kim DE, Jeong YJ, Liu KH, et al. Ursolic acid and its natural derivative corosolic acid suppress the proliferation of APC-mutated colon cancer cells through promotion of \u03b2-catenin degradation. Food Chem Toxicol. 2014;67:87\u201395.","journal-title":"Food Chem Toxicol"},{"key":"4164_CR41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mc.22776","volume":"57","author":"J Yang","year":"2018","unstructured":"Yang J, Wu R, Li W, Gao L, Yang Y, Li P, et al. The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP-C1 prostate cells. Mol Carcinog. 2018;57:512\u201321.","journal-title":"Mol Carcinog"},{"key":"4164_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13046-018-0889-x","volume":"37","author":"B Ma","year":"2018","unstructured":"Ma B, Zhang H, Wang Y, Zhao A, Zhu Z, Bao X, et al. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1\/JNK, PERK\/CHOP and TRIB3. J Exp Clin Cancer Res. 2018;37:210.","journal-title":"J Exp Clin Cancer Res"},{"key":"4164_CR43","doi-asserted-by":"publisher","first-page":"9719","DOI":"10.18632\/aging.102420","volume":"11","author":"L Ma","year":"2019","unstructured":"Ma L, Jiang H, Xu X, Zhang C, Niu Y, Wang Z, et al. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway. Aging. 2019;11:9719\u201337.","journal-title":"Aging"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04164-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:09:19Z","timestamp":1669972159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04164-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04164-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Institutional Ethics Committee of Shanghai Chest Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"889"}}